AI assistant
NovoCure Ltd — Director's Dealing 2017
Jan 4, 2017
31949_dirs_2017-01-04_d60b2d5a-0867-4292-848e-3e4a3ee2103d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-01-03
Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-03 | Ordinary Shares | J | 2242664 | — | Disposed | 0 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 19136038 | Indirect |
| Ordinary Shares | 84699 | Direct |
Footnotes
F1: On January 3, 2017, WFD Ventures Fund A, LLC distributed to its sole economic member all of the Issuer shares that it held in connection with its liquidation. Neither Mr. Doyle nor WFD Ventures Fund II, L.P. had any pecuniary interest in the distributed shares.
F2: Mr. Doyle is a managing director of WFD Ventures LLC, which is the managing member of WFD Ventures Fund A, LLC. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.
F3: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.